Martin A. Lehr, CEO of Context Therapeutics CNTX, has filed 7 purchases and 0 sales on the open market. The latest trade was on 02/19.

ML

ML

Martin A. Lehr

CEO

Company

Context Therapeutics CNTX

First filing

23/02/21

Trades

11 trades

Buys / sales

7 / 0

12-month net buying

No record

Last trade

02/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Context TherapeuticsCNTX	Open-market buy	25/06/09	25/06/10	100,000 sh	$0.70	$70,000	+12.2%
Context TherapeuticsCNTX	Open-market buy	23/02/21	23/02/21	5,823 sh	$0.84	$4,891.32	+3.8%
Context TherapeuticsCNTX	Open-market buy	23/02/13	23/02/13	5,606 sh	$0.87	$4,877.22	+3.8%
Context TherapeuticsCNTX	Open-market buy	23/02/06	23/02/06	5,040 sh	$0.97	$4,888.8	+3.5%
Context TherapeuticsCNTX	Open-market buy	23/01/30	23/01/30	7,027 sh	$0.70	$4,918.9	+5.2%
Context TherapeuticsCNTX	Open-market buy	23/01/23	23/01/23	6,839 sh	$0.72	$4,924.08	+5.3%
Context TherapeuticsCNTX	Open-market buy	23/01/17	23/01/18	6,783 sh	$0.74	$5,019.42	+5.5%